Inventor · disambiguated record
Christopher Mckinnon Lee
Also filed as: LEE CHRISTOPHER · LEE CHRISTOPHER MCKINNON
4 granted patents·10 pending applications·21 citations·filing 2019–2023
78Inventor score
Top patents by PatentIndex Score
14 records- 0195US11291728B2Anhydrous sodium thiosulfate and formulations thereofFENNEC PHARMACEUTICALS INC·Filed 2020·Granted Apr 5, 2022·7 cites·9 claims
- 0294US11617793B2Anhydrous sodium thiosulfate and formulations thereofFENNEC PHARMACEUTICALS INC·Filed 2022·Granted Apr 4, 2023·3 cites·8 claims
- 0394US11510984B2Anhydrous sodium thiosulfate and formulations thereofFENNEC PHARMACEUTICALS INC·Filed 2022·Granted Nov 29, 2022·3 cites·6 claims
- 0494US10792363B2Anhydrous sodium thiosulfate and formulations thereofFENNEC PHARMACEUTICALS INC·Filed 2019·Granted Oct 6, 2020·8 cites·27 claims
- 0587US2024350637A1Anhydrous Sodium Thiosulfate and Formulations ThereofFENNEC PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0687US2024165237A1Anhydrous Sodium Thiosulfate and Formulations ThereofFENNEC PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0786US2024042036A1Anhydrous sodium thiosulfate and formulations thereofFENNEC PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0884US2023201350A1Anhydrous sodium thiosulfate and formulations thereofFENNEC PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0984US2023201349A1Anhydrous sodium thiosulfate and formulations thereofFENNEC PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1084US2023201351A1Anhydrous sodium thiosulfate and formulations thereofFENNEC PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1179US2022160875A1Anhydrous sodium thiosulfate and formulations thereofFENNEC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1258US2024293404A1Salt and crystal forms of an epidermal growth factor receptor inhibitorBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 1356US2024300922A1Process for preparing egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 1454US2024254130A1Salt and solid forms of a kinase inhibitorBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Mckinnon Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →